PHARMEXCIL urges pharma industry to transition to innovation, complex generics, and R&D for global leadership. Focus on ...
Mark Mincy, CCO at US RX Care, exposes the conflicts of interest and hidden fees within the pharmacy benefits industry. He ...
India's pharmaceutical industry must shift towards innovation in complex generics, including peptides, biosimilars, and ...
The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on ...
Great pharmacy workforce redesign insights from 15 hospital pharmacy leaders on balancing short-term pressures with long-term transformation.
Experts warn a proposed 'data exclusivity' rule in India could severely delay affordable generic medicines, create drug monopolies, and threaten its role as the 'pharmacy of the world' ...
The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on ...
The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted ...
Medical Products Laboratories, based in Philadelphia, voluntarily recalled more than 41,000 1.5-ounce bottles of Walgreens ...
Medicare will save approximately 44%, on 15 high-cost medications as a result of the second round of the program’s drug price ...
The National Community Pharmacists Association (NCPA), the Pharmacy Technician Certification Board (PTCB) and PCCA have ...
WHAM – Rochester on MSN
New York to introduce regulations for pharmacy benefit managers
Rochester, N.Y. (WHAM) — In response to challenges within the pharmacy industry, Gov. Kathy Hochul announced new regulations ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈